<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2021-3053</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3053</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МНЕНИЕ ПРИГЛАШЕННОГО РЕДАКТОРА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OPINION OF INVITED EDITOR</subject></subj-group></article-categories><title-group><article-title>Инфламмейджинг в патогенезе хронических неинфекционных заболеваний</article-title><trans-title-group xml:lang="en"><trans-title>Inflammaging in the pathogenesis of chronic non­communicable diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0332-7696</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ким</surname><given-names>О. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Kim</surname><given-names>O. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Младший научный сотрудник отдела фундаментальных и прикладных аспектов ожирения.</p><p>Москва, Тел.: + 7 (901) 507­49­87</p></bio><bio xml:lang="en"><p>Moscow, + 7 (901) 507­49­87</p></bio><email xlink:type="simple">olgakimt06@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины” Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>15</day><month>10</month><year>2021</year></pub-date><volume>20</volume><issue>6</issue><fpage>3053</fpage><lpage>3053</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ким О.Т., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Ким О.Т.</copyright-holder><copyright-holder xml:lang="en">Kim O.T.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3053">https://cardiovascular.elpub.ru/jour/article/view/3053</self-uri><abstract><p>Читайте статью: Кривошапова К. Е., Масенко В. Л., Баздырев Е. Д., Барбараш О. Л. Остеосаркопеническое ожирение у пациентов с сердечно-сосудистыми заболеваниями. Спорные и нерешенные вопросы. в разделе Обзоры литературы, стр. 92­98.</p></abstract><trans-abstract xml:lang="en"><p>See Krivoshapova K. E., Masenko V. L., Bazdyrev E. D., Barbarash O. L. Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues in Review articles, pp. 92­98.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>старение</kwd><kwd>саркопения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>aging</kwd><kwd>sarcopenia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. (ссылка активна на 23.08.2021).</mixed-citation><mixed-citation xml:lang="en">Ageing and health. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health. (ссылка активна на 23.08.2021).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Marsman D, Belsky DW, Gregori D, et al. Healthy ageing: the natural consequences of good nutrition­a conference report. Eur J Nutr. 2018;57(Suppl 2):15­34. doi:10.1007/s00394­018­1723­0.</mixed-citation><mixed-citation xml:lang="en">Marsman D, Belsky DW, Gregori D, et al. Healthy ageing: the natural consequences of good nutrition­a conference report. Eur J Nutr. 2018;57(Suppl 2):15­34. doi:10.1007/s00394­018­1723­0.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709­13. doi:10.1016/j.cell.2014.10.039.</mixed-citation><mixed-citation xml:lang="en">Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709­13. doi:10.1016/j.cell.2014.10.039.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23­24):1565­76. doi:10.1101/gad.343129.120.</mixed-citation><mixed-citation xml:lang="en">Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes Dev. 2020;34(23­24):1565­76. doi:10.1101/gad.343129.120.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immunemetabolic viewpoint for age­related diseases. Nat Rev Endocrinol. 2018;14(10):576­90. doi:10.1038/s41574­018­0059­4.</mixed-citation><mixed-citation xml:lang="en">Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immunemetabolic viewpoint for age­related diseases. Nat Rev Endocrinol. 2018;14(10):576­90. doi:10.1038/s41574­018­0059­4.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ширинский В. С., Ширинский И. В. Полиморбидность, старение иммунной системы и системное вялотекущее воспаление — вызов современной медицине. Медицинская иммунология. 2020;22(4):609­24. doi:10.15789/1563­0625­PAO­2042.</mixed-citation><mixed-citation xml:lang="en">Shirinsky VS, Shirinsky IV. Polymorbidity. Ageing of immune system and low­grade systemic inflammation: a challenge for modern medicine. Medical Immunology (Russia). 2020;22(4):609­24. (In Russ.) doi:10.15789/1563­0625­PAO­2042.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Carter AJ, Nguyen AQ. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet. 2011;12:160. doi:10.1186/1471­2350­12­160.</mixed-citation><mixed-citation xml:lang="en">Carter AJ, Nguyen AQ. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet. 2011;12:160. doi:10.1186/1471­2350­12­160.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Van Den Biggelaar AH, De Craen AJ, Gussekloo J, et al. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 2004;18(9):1022­4. doi:10.1096/fj.03­1162fje.</mixed-citation><mixed-citation xml:lang="en">Van Den Biggelaar AH, De Craen AJ, Gussekloo J, et al. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 2004;18(9):1022­4. doi:10.1096/fj.03­1162fje.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Карамнова НАУЧНЫЙ СОТРУДНИК, Драпкина О.М. COVID­19 и питание: новые акценты, прежние приоритеты (обзор рекомендаций). Кардиоваскулярная терапия и профилактика. 2020;19(3):2576. doi:10.15829/1728­8800­2020­2576.</mixed-citation><mixed-citation xml:lang="en">Karamnova NS, Drapkina OM. COVID­19 and nutrition: new emphases, old priorities (review of guidelines). Cardiovascular Therapy and Prevention. 2020;19(3):2576. (In Russ.) doi:10.15829/1728­8800­2020­2576.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
